| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |